| Nom |
grayanotoxine III hémi (acétate d’éthyle)*adduit |
| Synonymes |
Grayanotoxine III ;Andromedol ; BRN 2059374 ; Désacétylandromédotoxine ; Déacylasebotoxine I ;Grayanotoxane-3,5,6,10,14,16-hexol, (3-bêta,6-bêta,14R)- ; NSC 323778 ; (3beta,6beta,14R)-Grayanotoxane-3,5,6,10,14,16-hexol ; 7,9a-méthano-9aH-cyclopenta(b)heptalene-2,4,8,11,11a,12(1H)-hexol, dodécahydro-1,1,4,8-tétraméthyl-, (2S,3as,4R,4ar,7R,8R,9as,11R,11aR,12R)- ; Grayanotoxane-3,5,6,10,14,16-hexol, (3beta,6beta,14R)- (9CI) ; grayanotoxane-3,5,6,10,14,16-hexol ; (1beta,3alpha,5alpha,6alpha,8beta,9alpha,10alpha,13beta,14S)-grayanotoxane-3,5,6,10,14,16-hexol ; (3beta,6beta)-grayanotoxane-3,5,6,10,14,16-hexol |
| Nom anglais |
grayanotoxin iii hemi(ethyl acetate)*adduct;Grayanotoxin III; Andromedol; BRN 2059374; Deacetylandromedotoxin; Deacylasebotoxin I; Grayanotoxane-3,5,6,10,14,16-hexol, (3-beta,6-beta,14R)-; NSC 323778; (3beta,6beta,14R)-Grayanotoxane-3,5,6,10,14,16-hexol; 7,9a-Methano-9aH-cyclopenta(b)heptalene-2,4,8,11,11a,12(1H)-hexol, dodecahydro-1,1,4,8-tetramethyl-, (2S,3as,4R,4ar,7R,8R,9as,11R,11aR,12R)-; Grayanotoxane-3,5,6,10,14,16-hexol, (3beta,6beta,14R)- (9CI); grayanotoxane-3,5,6,10,14,16-hexol; (1beta,3alpha,5alpha,6alpha,8beta,9alpha,10alpha,13beta,14S)-grayanotoxane-3,5,6,10,14,16-hexol; (3beta,6beta)-grayanotoxane-3,5,6,10,14,16-hexol |
| Formule moléculaire |
C20H34O6 |
| Poids Moléculaire |
370.4804 |
| InChI |
InChI=1/C20H34O6/c1-16(2)13(21)7-12-18(4,25)11-6-5-10-15(23)19(11,9-17(10,3)24)8-14(22)20(12,16)26/h10-15,21-26H,5-9H2,1-4H3/t10?,11-,12-,13-,14+,15?,17+,18+,19-,20-/m0/s1 |
| Numéro de registre CAS |
4678-45-9 |
| Structure moléculaire |
|
| Densité |
1.36g/cm3 |
| Point d'ébullition |
552.6°C at 760 mmHg |
| Indice de réfraction |
1.619 |
| Point d'éclair |
250.9°C |
| Pression de vapeur |
1.63E-14mmHg at 25°C |
| Les symboles de danger |
|
| Codes des risques |
|
| Description de sécurité |
|
|
FR
CN
CZ
DE
EN
ES
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PL
PT
RU
SA
TR
